These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16060412)

  • 21. Combination therapy with nifedipine GITS 60 mg: subanalysis of a prospective, 12-week observational study (AdADOSE).
    Motaweih AK; Usova E; Hussain W; Dello Z; Petri T
    Clin Exp Hypertens; 2016; 38(1):71-80. PubMed ID: 26331311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
    Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
    Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
    Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early intervention of long-acting nifedipine GITS reduces brachial-ankle pulse wave velocity and improves arterial stiffness in Chinese patients with mild hypertension: a 24-week, single-arm, open-label, prospective study.
    Zhang J; Wang Y; Hu H; Yang X; Tian Z; Liu D; Gu G; Zheng H; Xie R; Cui W
    Drug Des Devel Ther; 2016; 10():3399-3406. PubMed ID: 27799740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.
    Sareli P; Radevski IV; Valtchanova ZP; Libhaber E; Candy GP; Den Hond E; Libhaber C; Skudicky D; Wang JG; Staessen JA
    Arch Intern Med; 2001 Apr; 161(7):965-71. PubMed ID: 11295959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
    Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
    Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation.
    Patki KC; Joglekar SJ; Kamat SK; Thatte UM; Yeolekar ME; Rege NN; Dahanukar SA; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():26-9. PubMed ID: 11229106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifedipine GITS replacing nifedipine SR: ambulatory blood pressure assessment of efficacy.
    Rahima-Maoz C; Grossman E; Nussinovitch N; Katz A; Rosenthal T
    Cardiology; 1997; 88 Suppl 3():43-6. PubMed ID: 9397293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients.
    Polónia J; Boaventura I; Gama G; Camões I; Bernardo F; Andrade P; Nunes JP; Brandão F; Cerqueira-Gomes M
    J Hypertens; 1995 Aug; 13(8):925-31. PubMed ID: 8557971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nifedipine gastrointestinal therapeutic system (GITS) for hypertensive patients in a primary care setting: results of the Extended Release Adalat Canadian Trial (EXACT).
    Toal CB; Mahon WA; Barnes C; Burelle D
    Clin Ther; 1997; 19(5):924-35. PubMed ID: 9385481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension.
    Leu HB; Charng MJ; Ding PY
    Jpn Heart J; 2004 Jul; 45(4):623-35. PubMed ID: 15353873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension.
    Houston MC; Olafsson L; Burger MC
    Angiology; 1991 Sep; 42(9):681-90. PubMed ID: 1928808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A randomized double-blind therapeutic trial of enalapril versus timed-release nifedipine in mild to moderate essential hypertension].
    Artigou JY; Benichou M; Berland J; Fressinaud P; Grollier G; Guéret P; Nguyen Cong Duc L
    Presse Med; 1990 Jan 6-13; 19(1):13-6. PubMed ID: 2137218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension.
    Isles CG; Kitchin NR
    J Hum Hypertens; 1999 Jan; 13(1):69-73. PubMed ID: 9928755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial on the blood pressure-lowering effect of amlodipine and nifedipine-GITS in sustained hypertension.
    Huang QF; Sheng CS; Li Y; Dou Y; Zheng MS; Zhu ZM; Wang JG;
    J Clin Hypertens (Greenwich); 2019 May; 21(5):648-657. PubMed ID: 30973207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC.
    Wurdeman RL; Mooss AN; Mohiuddin SM; Lucas BD; Ryschon KL; Hilleman DE
    Pharmacotherapy; 1999 Jan; 19(1):94-100. PubMed ID: 9917082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
    Kirby BJ; Kitchin NR
    Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.